{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:31:57Z","timestamp":1772832717939,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Orthopaedic Science"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1007\/s00776-004-0809-0","type":"journal-article","created":{"date-parts":[[2004,9,23]],"date-time":"2004-09-23T13:20:32Z","timestamp":1095945632000},"page":"521-525","source":"Crossref","is-referenced-by-count":24,"title":["Oral alendronate treatment for polyostotic fibrous dysplasia: a case report"],"prefix":"10.1016","volume":"9","author":[{"given":"Yasuyuki","family":"Kitagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromoto","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s00776-004-0809-0_bb0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1210\/jcem-31-3-283","article-title":"Effects of calcitonin in Paget\u2019s disease and polyostotic fibrous dysplasia","volume":"31","author":"Bell","year":"1970","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1007\/s00776-004-0809-0_bb0010","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1359\/jbmr.1997.12.10.1746","article-title":"Long-term effects of intravenous pamidronate in fibrous dysplasia of bone","volume":"12","author":"Chapurlat","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1007\/s00776-004-0809-0_bb0015","series-title":"Bone tumors: general aspects and data on 8,542 cases","first-page":"413","year":"1986"},{"key":"10.1007\/s00776-004-0809-0_bb0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00002281-200007000-00017","article-title":"Treatment of bone diseases with bisphosphonates, excluding osteoporosis","volume":"12","author":"Devogelaer","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1007\/s00776-004-0809-0_bb0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00223-001-1098-7","article-title":"Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia","volume":"71","author":"Isaia","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1007\/s00776-004-0809-0_bb0030","first-page":"894","article-title":"Oral bisphosphonates in polyostotic fibrous dysplasia","volume":"40","author":"Khadilker","year":"2003","journal-title":"Indian Pediatr"},{"key":"10.1007\/s00776-004-0809-0_bb0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/PL00012044","article-title":"The bisphosphonate incadronate for bone metastases of breast cancer","volume":"5","author":"Koizumi","year":"2000","journal-title":"Int J Clin Oncol"},{"key":"10.1007\/s00776-004-0809-0_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02967621","article-title":"Bone metabolic markers in bisphosphonate therapy for skeletal metastases in patients with breast cancer","volume":"10","author":"Koizumi","year":"2003","journal-title":"Breast Cancer"},{"key":"10.1007\/s00776-004-0809-0_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1651-2227.2000.tb01214.x","article-title":"Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome","volume":"89","author":"Lala","year":"2000","journal-title":"Acta Paediatr"},{"key":"10.1007\/s00776-004-0809-0_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003086-200101000-00003","article-title":"Bisphosphonate therapy in fibrous dysplasia","volume":"382","author":"Lane","year":"2001","journal-title":"Clin Orthop"},{"key":"10.1007\/s00776-004-0809-0_bb0055","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(94)90069-8","article-title":"Long-term effects of intravenous pamidronate in fibrous dysplasia of bone","volume":"343","author":"Liens","year":"1994","journal-title":"Lancet"},{"key":"10.1007\/s00776-004-0809-0_bb0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02949307","article-title":"Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: aetiological and therapeutic implications","volume":"157","author":"Long","year":"1988","journal-title":"Ir J Med Sci"},{"key":"10.1007\/s00776-004-0809-0_bb0065","first-page":"929","article-title":"Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome","volume":"15","author":"Matarazzo","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1007\/s00776-004-0809-0_bb0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/JCD:4:2:167","article-title":"Bone mineral density response to long-term bisphosphonate therapy in fibrous dysplasia","volume":"4","author":"Parisi","year":"2001","journal-title":"J Clin Densitom"},{"key":"10.1007\/s00776-004-0809-0_bb0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1507\/endocrj.45.191","article-title":"A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis","volume":"45","author":"Shiraki","year":"1998","journal-title":"Endocr J"},{"key":"10.1007\/s00776-004-0809-0_bb0080","first-page":"1511","article-title":"Fibrous dysplasia of bone: the bone lesion unmasked","volume":"151","author":"Singer","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1007\/s00776-004-0809-0_bb0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0002-9343(96)00282-3","article-title":"Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis","volume":"101","author":"Tucci","year":"1996","journal-title":"Am J Med"},{"key":"10.1007\/s00776-004-0809-0_bb0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1200\/JCO.1997.15.1.131","article-title":"Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy","volume":"15","author":"Vinholes","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1007\/s00776-004-0809-0_bb0095","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune-Albright syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1007\/s00776-004-0809-0_bb0100","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1359\/jbmr.1997.12.8.1314","article-title":"Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density","volume":"12","author":"Weinstein","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1007\/s00776-004-0809-0_bb0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI118773","article-title":"Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome","volume":"98","author":"Yamamoto","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1007\/s00776-004-0809-0_bb0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s007740200024","article-title":"Alendronate and pharmacological doses of 1\u03b1 OHD3 therapy in a patient with McCune-Albright syndrome and accompanying hypophosphatemia","volume":"20","author":"Yamamoto","year":"2002","journal-title":"J Bone Miner Metab"},{"key":"10.1007\/s00776-004-0809-0_bb0115","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1067\/mpd.2000.107836","article-title":"Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome","volume":"137","author":"Zacharin","year":"2000","journal-title":"J Pediatr"}],"container-title":["Journal of Orthopaedic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265815328220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265815328220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00776-004-0809-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T18:54:51Z","timestamp":1549220091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0949265815328220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0949265815328220"],"URL":"https:\/\/doi.org\/10.1007\/s00776-004-0809-0","relation":{},"ISSN":["0949-2658"],"issn-type":[{"value":"0949-2658","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}